您当前的位置：
首页 >
文章列表页 >
Effect and Immunoinflammatory Mechanism of Ruyi Zhenbaowan in Treatment of Secondary Brain Injury and Central Pain in Hemorrhagic Stroke Mice
更新时间：2024-11-18

    • Effect and Immunoinflammatory Mechanism of Ruyi Zhenbaowan in Treatment of Secondary Brain Injury and Central Pain in Hemorrhagic Stroke Mice

      增强出版
    • “Ruyi Zhenbao Pill can effectively alleviate secondary injury and central pain in hemorrhagic stroke mice. Its mechanism is related to regulating the CX3CL1-CX3CR1 axis, inhibiting microglial cell infiltration and activation, promoting vascular repair atypical monocyte infiltration, and inhibiting inflammatory phagocytic typical monocyte infiltration.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 24, Pages: 47-56(2024)

    • DOI：10.13422/j.cnki.syfjx.20240644    

      CLC： R2-0;R33;R742;R24

    • Received：18 February 2024，

      Published Online：25 June 2024，

      Published：20 December 2024

    移动端阅览

  • WANG Wenli,ZHANG Guoxin,LIU Ying,et al.Effect and Immunoinflammatory Mechanism of Ruyi Zhenbaowan in Treatment of Secondary Brain Injury and Central Pain in Hemorrhagic Stroke Mice[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(24):47-56. DOI： 10.13422/j.cnki.syfjx.20240644.

  •  
  •  

0

Views

83

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Pharmacodynamic Characteristics and Neuroinflammatory Mechanisms of Ruyi Zhenbaowan in Treating Nociceptive Hypersensitivity and Central Sensitisation of Spinal Cord in Mouse Model of Central Post-stroke Pain
Mechanism of Congrong Zonggan Capsules in Improving Neuroinflammation and Cognitive Impairment in 5×FAD Mice Based on NF-κB/NLRP3 Signaling Pathway
Mechanism of Wenyang Jieyu Prescription in Regulating Activation of Mouse Hippocampal Microglia Based on JAK2/STAT3 Signaling Pathway
Modified Xiehuangsan Regulates Microglial Polarization and TLR4/MyD88/NF-κB Pathway to Treat Tic Disorders in Rats

Related Author

HUANG Aoqing
WANG Wenli
WANG Hai ping
LIN Na
ZHOU Yanru
GU Xinru
LIU Yuru
ZHANG Shun

Related Institution

Science and Technology Innovation Center，Guangzhou University of Chinese Medicine
Arura Tibetan Medicine Co.Ltd.
State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture，Nanjing University of Chinese Medicine，Jiangsu Kanion Pharmaceutical Co. Ltd.
Kanion School of Chinese Materia Medica，Nanjing University of Chinese Medicine
Institute of Basic Theory for Chinese Medicine，China Academy of Chinese Medical Sciences
0